Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
Conditions: Clinical High Risk for Psychosis; Ultra High Risk for Psychosis; Attenuated Psychotic Symptoms Intervention: Dietary Supplement: Ultra-micronized Palmitoylethanolamide (PEA) Sponsors: University of Udine; National Research Council (CNR), Institute of Biomolecular Chemistry (ICB), Italy Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials